Future Pak’s most recent bid for Theratechnologies won over the HIV drugmaker’s board and a special sale committee. The CDMO has been chasing a Theratechnologies buyout since at least August of last year. More: HIV drugmaker Theratechnologies agrees to 4M
read moreAfter several PD-1xVEGF competitors forged alliances with Big Pharma players, Summit Therapeutics, the frontrunner in this hot cancer drug field, is reportedly seeking its own deal. More: Amid B AstraZeneca partnership rumor, Summit needs .7B upfront to excite investors: analyst
read more
PulseSight begins phase 1 safety study of gene therapy for geographic atrophy More: First patient dosed in trial for novel dry AMD treatment PST-611 Source: News
read more
SMC approval provides option for postmenopausal women at risk of fractures More: Eladynos recommended for osteoporosis treatment in Scottish NHS Source: News
read more
CSL Behring marks new era in treatment with milestone reimbursement model More: First German haemophilia B patient receives gene therapy HEMGENIX Source: News
read more
Pneumagen’s intranasal antiviral demonstrates reduced infection More: Neumifil shows promise in treating influenza with positive phase 2 dat Source: News
read more© 1994 - 2025 B.M. Pharmaceuticals